Canine brain tumours: a model for the human disease?
J Hicks, S Platt, M Kent, A Haley - Veterinary and comparative …, 2017 - Wiley Online Library
Canine brain tumours are becoming established as naturally occurring models of disease to
advance diagnostic and therapeutic understanding successfully. The size and structure of …
advance diagnostic and therapeutic understanding successfully. The size and structure of …
[HTML][HTML] Genetic/molecular alterations of meningiomas and the signaling pathways targeted
P Domingues, M González-Tablas, Á Otero… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Meningiomas are usually considered to be benign central nervous system tumors; however,
they show heterogenous clinical, histolopathological and cytogenetic features associated …
they show heterogenous clinical, histolopathological and cytogenetic features associated …
Recurrence/regrowth in grade I meningioma: how to predict?
GTC Carvalho, WC Silva-Martins… - Frontiers in …, 2020 - frontiersin.org
The HLA-G and HLA-E molecules, Ki67, progesterone (PR), estrogen (ER) and androgen
receptors (AR), p53, COX-2, and HER2 were studied to assess whether the biological …
receptors (AR), p53, COX-2, and HER2 were studied to assess whether the biological …
The role of systemic inflammatory cells in meningiomas
J Haslund-Vinding, JR Møller, M Ziebell, F Vilhardt… - Neurosurgical …, 2022 - Springer
The aim of this review is to describe the inflammatory systemic cell infiltrate and its role in
pathophysiology and prognostic implications of meningiomas. Articles from PubMed …
pathophysiology and prognostic implications of meningiomas. Articles from PubMed …
Impact of shape irregularity in medial sphenoid wing meningiomas on postoperative cranial nerve functioning, proliferation, and progression-free survival
J Wach, J Naegeli, M Vychopen, C Seidel… - Cancers, 2023 - mdpi.com
Simple Summary The shape of meningiomas has been suggested as a potential indicator of
the WHO grade. Medial sphenoid wing meningiomas are surgically challenging skull base …
the WHO grade. Medial sphenoid wing meningiomas are surgically challenging skull base …
Systemic therapy for recurrent meningioma
E Le Rhun, S Taillibert… - Expert review of …, 2016 - Taylor & Francis
ABSTRACT Introduction: Meningioma comprise 20-30% of all primary brain tumors.
Notwithstanding surgery and radiotherapy, a subset of patients will manifest recurrent …
Notwithstanding surgery and radiotherapy, a subset of patients will manifest recurrent …
Poly (ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas
Meningiomas are one of the most frequent intracranial tumours, with 13 histological types
and three grades according to the 2007 WHO Classification of Tumours of the Central …
and three grades according to the 2007 WHO Classification of Tumours of the Central …
Immunohistochemical characterization of procaspase-3 overexpression as a druggable target with PAC-1, a procaspase-3 activator, in canine and human brain …
Gliomas and meningiomas are the most common brain neoplasms affecting both humans
and canines, and identifying druggable targets conserved across multiple brain cancer …
and canines, and identifying druggable targets conserved across multiple brain cancer …
[HTML][HTML] Expression and clinical significance of cyclooxygenase‑2 and interleukin‑32 in primary gastric B‑cell lymphoma
Y Cui, Z Sun, X Li, C Leng, L Zhang… - Oncology …, 2016 - spandidos-publications.com
Abstract Cyclooxygenase‑2 (COX‑2) and interleukin‑32 (IL‑32) expression has been
examined in various carcinomas and inflammations, and has been suggested to be …
examined in various carcinomas and inflammations, and has been suggested to be …
Association between nonsteroidal anti‐inflammatory drug use and brain tumour risk: a meta‐analysis
Y Liu, Y Lu, J Wang, L Xie, T Li, Y He… - British journal of …, 2014 - Wiley Online Library
Aims Several epidemiological studies have evaluated the association between nonsteroidal
anti‐inflammatory drugs (NSAID s) and brain tumour risk. However, results from these …
anti‐inflammatory drugs (NSAID s) and brain tumour risk. However, results from these …